Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Europe Agreement on EC make-up could include cannabis-conservative health commissioner ...
  • Ukraine New additions to list of prohibited psychotropic substances ...
  • Germany BfArM published medical cannabis import data for for Q3 2024 ...
  • Denmark Government plans to make medical cannabis scheme permanent ...
  • United States Senate committee releases Farm Bill draft ...
  • Luxembourg Medical cannabis patients to see restrictions in 2025 ...
  • Moldova Passed amendment allows for registered hemp varieties to be cultivated ...
  • Germany Cannabis legalisation debate takes place ahead of snap elections ...
  • Ireland Ruling parties disagree on proposal to decriminalise personal drug use ...
  • Brazil Up to 0.3% THC in plants authorised for medical, pharmaceutical, industrial use ...
  • Australia Parliamentary committee makes suggestions for cannabis law in NSW ...
  • Australia Greens announce Parliament will vote on cannabis legalisation this month ...
View all
Regulatory reports

A highly restrictive regime: Australia regulatory report

Written by || 29th November 2018 || Regulatory reports | Regulation and legislation | GeographiesAustralasia Australia

Australia is a highly restrictive market for CBD, with limits on growing and extraction and an absolute prohibition on CBD in consumer products. Only approved CBD-containing medical products are allowed on the market.

Any extract of cannabis – including CBD – is considered an illegal narcotic or a medicine and only allowed on the market if a pharmaceutical or medical licence is obtained in advance, irrespective of THC content.

Hemp can be farmed and exported provided a licence from the relevant sub-national entities is obtained, but legitimate uses for the plant are limited.

Read more
I'm already a subscriber

Login

Pablo Cano Trilla

Head of legal analysis
Pablo runs our regulatory analysis team, leading our international, US and EU coverage in regulatory reports and trackers. Pablo holds an LLM with Distinction from the University of Aberdeen, an LLB in law from the Autonomous University of Madrid and a BA in political science from Pompeu Fabra University. Pablo is a qualified attorney, specialised in international law, EU law & politics, and property law.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.